🔎 Trials Near Me

Početna › KOPB › Texas › El Paso

Kliničke studije za KOPB u gradu El Paso, TX

5 studija za KOPB traži sudionike na lokacijama u gradu El Paso i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

U tijeku regrutacijaFaza 3
  • Research Site, El Paso
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

U tijeku regrutacijaFaza 3
  • El Paso Pulmonary Association- Site Number : 8400033, El Paso
Od 40 do 80 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07190222

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

U tijeku regrutacijaFaza 2
  • Research Site, El Paso
Od 40 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

U tijeku regrutacijaFaza 3
  • Research Site, El Paso
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06878261

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

U tijeku regrutacijaFaza 3
  • GSK Investigational Site, El Paso
Od 40 do 80 godina · Oba spola · Ažurirano 9. tra 2026. · NCT06961214

Studije za KOPB u drugim gradovima

Ostale studije u gradu El Paso

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.